Explore our services

In the media

Stay informed with the latest news!

In the press

logo-b4b-violet
Buzz4bio
January 29, 2024
Supply chain des produits de thérapie cellulaire et génique
logo_actulabo
Actulabo
January 24, 2024
Creapharm accroît ses capacités de stockage froid et cède ses activités cosmétiques à PLC
POLEPHARMA_Logo
Polepharma
January 12, 2024
CREAPHARM BIO&PHARMA investit une nouvelle fois pour accroitre ses capacités de stockage froid
Design sans titre (16)
Mabdesign
December 20, 2023
CREAPHARM BIO&PHARMA investit une nouvelle fois pour accroitre ses capacités de stockage froid
POLEPHARMA_Logo
Polepharma
October 13, 2023
CREAPHARM BIOSERVICES obtient de l’ANSM l’autorisation d’ouverture d’établissements pharmaceutiques et étend ses activités aux médicaments de thérapie innovante
Design sans titre (16)
Mabdesign
September 1, 2023
CREAPHARM BIOSERVICES obtained Manufacturer’s Authorisation from the ANSM

Our latest news

myonex logo (1)
CREAPHARM BIO&PHARMA
MYONEX CLOSES CREAPHARM ACQUISITION EXPANDING GLOBAL SERVICES
Horsham, PA, USA May 2, 2024 - Myonex has completed the previously announced acquisition of CREAPHARM’s pharmaceutical services business. This transaction combines capabilities and flexibility to serve pharmaceutical and biotech companies in both clinical and commercial stages, including companies managing Advanced Therapies. Creapharm’s clinical packaging and distribution services, commercial packaging operations and bioservices will now be known as Creapharm, a Myonex company.
myonex logo (1)
CREAPHARM BIO&PHARMA
MYONEX TO ACQUIRE CREAPHARM'S CLINICAL & COMMERCIAL PACKAGING AND BIOSERVICES BUSINESS
Horsham, PA, USA March 15, 2024 – Myonex, a leading global clinical trial supply company, has reached an agreement with the owners of Creapharm Group to acquire the Creapharm Clinical Packaging & Distribution and Commercial Packaging business and bioservices, headquartered in Reims, France with additional locations in Bordeaux and Bailly-Romainvilliers, France, and Marietta, Georgia, USA.
12222
CREAPHARM BIO&PHARMA
[FR] CREAPHARM BIO&PHARMA INVESTIT UNE NOUVELLE FOIS POUR ACCROITRE SES CAPACITES DE STOCKAGE FROID
Depuis plus de 30 ans, CREAPHARM met un point d’honneur à offrir des solutions en parfaite adéquation avec les besoins spécifiques du marché des produits de santé.
CREAPHARM-BIOSERVICES_Ultra-low-temperature-storage-768x290-1
Creapharm Bioservices
AUTHORIZED AS A PHARMACEUTICAL COMPANY BY FRENCH REGULATORY AUTHORITIES (ANSM), CREAPHARM BIOSERVICES EXPANDS ITS SCOPE TO INCLUDE ADVANCED THERAPY MEDICINAL PRODUCTS
On the occasion of its third aniversary, the biobank which integrated CREAPHARM GROUP as CREAPHARM BIOSERVICES, got its Manufacturer’s Authorisation from the French National Agency for Medicines and Health Products (ANSM*) on August 21th 2023.
hmnc_creapharm_delpharm
Creapharm Clinical Supply
DELPHARM & CREAPHARM announced they have successfully joined forces to better serve HMNC Brain Health and met the FPI deadline in its BH-200-03 European phase 2 clinical trial.
DELPHARM and CREAPHARM announced today that they have combined their expertises to synergistically support HMNC Brain Health, a global clinical-stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry.
CREAPHARM-BIOSERVICES_Nitrogen-tanks-80°C-for-highly-secure-storage-a-first-in-France
Creapharm Bioservices
The French-speaking Diabetes Society is seeking the expertise of three leaders in the French biobanking ecosystem to accelerate the identification of new factors associated with major cardiovascular events (MACE*) in patients.
*(major adverse cardiovascular events)
In the media

Stay informed with the latest news!

In the press

logo-b4b-violet
Buzz4bio
January 29, 2024
Supply chain des produits de thérapie cellulaire et génique
logo_actulabo
Actulabo
January 24, 2024
Creapharm accroît ses capacités de stockage froid et cède ses activités cosmétiques à PLC
POLEPHARMA_Logo
Polepharma
January 12, 2024
CREAPHARM BIO&PHARMA investit une nouvelle fois pour accroitre ses capacités de stockage froid
Design sans titre (16)
Mabdesign
December 20, 2023
CREAPHARM BIO&PHARMA investit une nouvelle fois pour accroitre ses capacités de stockage froid
POLEPHARMA_Logo
Polepharma
October 13, 2023
CREAPHARM BIOSERVICES obtient de l’ANSM l’autorisation d’ouverture d’établissements pharmaceutiques et étend ses activités aux médicaments de thérapie innovante
Design sans titre (16)
Mabdesign
September 1, 2023
CREAPHARM BIOSERVICES obtained Manufacturer’s Authorisation from the ANSM
logo-b4b-violet
Buzz4bio
July 13, 2023
Mise en synergie des expertises de Delpharm et Creapharm pour accompagner HMNC Brain Health
POLEPHARMA_Logo
Polepharma
July 7, 2023
DELPHARM & CREAPHARM annoncent avoir uni leurs forces pour offrir le meilleur accompagnement à HMNC Brain Health
MABDESIGN-LOGO
Mabdesign
July 3, 2023
DELPHARM & CREAPHARM announced they have successfully joined forces to better serve HMNC Brain Health and met the FPI deadline in its BH-200-03 European phase 2 clinical trial
logo-buzz4bio
Buzz4Bio
February 15, 2023
Supply chain des biomédicaments des phases de recherche à la commercialisation
Logo_ITD_general
Innovative Therapies Days
July 28, 2022
CREAPHARM demonstrates unparalleled performance of -80°c nitrogen tank technology
LA-TRIBUNE-LOGO
La Tribune
July 26, 2022
CREAPHARM : stocker, conditionner et distribuer les médicaments les plus innovants
logo-france-biotech
France Biotech
July 25, 2022
CREAPHARM demonstrates unparalleled performance of -80°c nitrogen tank technology
MABDESIGN-LOGO
Mabdesign
July 25, 2022
CREAPHARM demonstrates unparalleled performance of -80°c nitrogen
PMT-LOGO
PMT
July 25, 2022
CREAPHARM démontre les performances inégalées de la technologie de réservoir d’azote à -80°C
PMT-LOGO
PMT
April 8, 2022
CREAPHARM BIOSERVICES réalise une première en France
MABDESIGN-LOGO
Mabdesign
April 6, 2022
Nitrogen Tanks -80°C for highly-secure storage, a first in France
LA-TRIBUNE-LOGO
La Tribune
January 22, 2022
Paroles d'Experts CREAPHARM : le spécialiste du conditionnement et de la distribution de médicaments
POLEHARMA-LOGO
Polepharma
September 10, 2021
CREAPHARM GROUP finalise sa prise de participation majoritaire au capital de Linbox : naissance de CREAPHARM BIOSERVICES
MIND-HEALTH-LOGO
MindHealth
April 20, 2021
Comment a émergé un standard GS1 Datamatrix pour les produits d’investigation clinique

Swipe to see more

Our latest news

myonex logo (1)
CREAPHARM BIO&PHARMA
MYONEX CLOSES CREAPHARM ACQUISITION EXPANDING GLOBAL SERVICES
Horsham, PA, USA May 2, 2024 - Myonex has completed the previously announced acquisition of CREAPHARM’s pharmaceutical services business. This transaction combines capabilities and flexibility to serve pharmaceutical and biotech companies in both clinical and commercial stages, including companies managing Advanced Therapies. Creapharm’s clinical packaging and distribution services, commercial packaging operations and bioservices will now be known as Creapharm, a Myonex company.
myonex logo (1)
CREAPHARM BIO&PHARMA
MYONEX TO ACQUIRE CREAPHARM'S CLINICAL & COMMERCIAL PACKAGING AND BIOSERVICES BUSINESS
Horsham, PA, USA March 15, 2024 – Myonex, a leading global clinical trial supply company, has reached an agreement with the owners of Creapharm Group to acquire the Creapharm Clinical Packaging & Distribution and Commercial Packaging business and bioservices, headquartered in Reims, France with additional locations in Bordeaux and Bailly-Romainvilliers, France, and Marietta, Georgia, USA.
12222
CREAPHARM BIO&PHARMA
[FR] CREAPHARM BIO&PHARMA INVESTIT UNE NOUVELLE FOIS POUR ACCROITRE SES CAPACITES DE STOCKAGE FROID
Depuis plus de 30 ans, CREAPHARM met un point d’honneur à offrir des solutions en parfaite adéquation avec les besoins spécifiques du marché des produits de santé.
CREAPHARM-BIOSERVICES_Ultra-low-temperature-storage-768x290-1
Creapharm Bioservices
AUTHORIZED AS A PHARMACEUTICAL COMPANY BY FRENCH REGULATORY AUTHORITIES (ANSM), CREAPHARM BIOSERVICES EXPANDS ITS SCOPE TO INCLUDE ADVANCED THERAPY MEDICINAL PRODUCTS
On the occasion of its third aniversary, the biobank which integrated CREAPHARM GROUP as CREAPHARM BIOSERVICES, got its Manufacturer’s Authorisation from the French National Agency for Medicines and Health Products (ANSM*) on August 21th 2023.
hmnc_creapharm_delpharm
Creapharm Clinical Supply
DELPHARM & CREAPHARM announced they have successfully joined forces to better serve HMNC Brain Health and met the FPI deadline in its BH-200-03 European phase 2 clinical trial.
DELPHARM and CREAPHARM announced today that they have combined their expertises to synergistically support HMNC Brain Health, a global clinical-stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry.
CREAPHARM-BIOSERVICES_Nitrogen-tanks-80°C-for-highly-secure-storage-a-first-in-France
Creapharm Bioservices
The French-speaking Diabetes Society is seeking the expertise of three leaders in the French biobanking ecosystem to accelerate the identification of new factors associated with major cardiovascular events (MACE*) in patients.
*(major adverse cardiovascular events)
CREAPHARM-BIOSERVICES_Ultra-low-temperature-storage-768x290-1
Creapharm Bioservices
CREAPHARM DEMONSTRATES UNPARALLELED PERFORMANCE OF -80°C NITROGEN TANK TECHNOLOGY
CREAPHARM BIOSERVICES has recently invested in -80°C nitrogen tanks to provide Biotechs and Research key players with a new solution to meet the challenges of ultra-low temperature storage.
CREAPHARM-BIOSERVICES_Nitrogen-tanks-80°C-for-highly-secure-storage-a-first-in-France
Creapharm Bioservices
NITROGEN TANKS -80°C FOR HIGHLY- SECURE STORAGE, A FIRST IN FRANCE
CREAPHARM BIOSERVICES announces its investment in -80°C nitrogen tanks to provide the European ultra-low temperature storage market with unparalleled performance.
CREAPHARM-BIOSERVICES_CREAPHARM-GROUP-finalise-sa-prise-de-participation-majoritaire-au-capital-de-LinBox-2048x922
Creapharm Group
CREAPHARM GROUP FINALISE SA PRISE DE PARTICIPATION MAJORITAIRE AU CAPITAL DE LINBOX : NAISSANCE DE CREAPHARM BIOSERVICES
Eric PLACET, CEO de CREAPHARM GROUP et les cofondateurs de LinBox, Marine THIEBAUD, Ludivine MIOSSEC et Frédéric MALBOZE annoncent ce jour avoir signé un accord entre leurs sociétés respectives. C’est au travers d’une prise de participation majoritaire au capital de la société LinBox que CREAPHARM GROUP étend ses activités au biobanking, en créant CREAPHARM BIOSERVICES.

Swipe to see more

Introducing

Myonex closes Creapharm acquisition expanding global services.